APA Citatie

Mead, G. M., Barrans, S. L., Qian, W., Walewski, J., Radford, J. A., Wolf, M., . . . Jack, A. S. (2008). A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). American Society of Hematology.

Chicago Style citaat

Mead, Graham M., et al. A Prospective Clinicopathologic Study of Dose-modified CODOX-M/IVAC in Patients With Sporadic Burkitt Lymphoma Defined Using Cytogenetic and Immunophenotypic Criteria (MRC/NCRI LY10 Trial). American Society of Hematology, 2008.

MLA citatie

Mead, Graham M., et al. A Prospective Clinicopathologic Study of Dose-modified CODOX-M/IVAC in Patients With Sporadic Burkitt Lymphoma Defined Using Cytogenetic and Immunophenotypic Criteria (MRC/NCRI LY10 Trial). American Society of Hematology, 2008.